IMTX Competitors & Alternatives
Compare Immatics NV with similar stocks in the same industry
Biotechnology
IMTX
Main Stock$8.79
Tradestie Score
43
Market Cap
$1.09B
Revenue Growth
0.9%
Analyst Upside
+100.6%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RCUS
Arcus Biosciences, Inc.
|
$24.59
|
$1.43B | - | 42 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$17.10
|
$1.42B | - | 41 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$18.18
|
$1.35B | - | 46 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$43.62
|
$1.32B | - | 47 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$7.45
|
$1.29B | - | 47 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$29.03
|
$1.29B | - | 57 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.58
|
$1.29B | - | 40 | Compare |
|
ZYME
Zymeworks Inc.
|
$26.24
|
$1.28B | - | 37 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$6.07
|
$1.27B | - | 40 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
More IMTX Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2836)
234 stocks in this industry